Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.
about
A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGDTissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma.Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC.
P2860
Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@ast
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@en
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@nl
type
label
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@ast
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@en
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@nl
prefLabel
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@ast
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@en
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@nl
P2093
P2860
P356
P1476
Factor VII light chain-targete ...... tic efficacy for liver cancer.
@en
P2093
Caihong Li
Junnian Zheng
Qing Zhang
Shuangshuang Xu
Xiujun Liu
Yang Zhang
P2860
P304
P356
10.1089/CBR.2012.1209
P577
2012-05-31T00:00:00Z